98%
921
2 minutes
20
Background: This study aimed to assess whether the expression difference of cortisol in umbilical cord blood is associated with dichorionic twin inconsistent growth.
Methods: This research included 108 patients with dichorionic twin pregnancy delivered at Jiaxing Maternity and Child Health Care Hospital between January 2021 and December 2024. Depending on whether or not they had twin inconsistent growth, participants were classified into the discordant twins (DT) group (47 pairs of discordant twins) as the experimental group and the concordant twins (CT) group (61 pairs of concordant twins) as the control group. According to the medical record, the maternal and neonatal information of the two groups were collected, and the differences in the basic conditions between the two groups of maternal and twin fetuses were analyzed. The fetal birth weight of the two groups was weighed, and the cortisol content of the umbilical cord blood was measured by chemiluminescence.
Results: There were no significant differences in maternal age, gestational age (GA), parity, body and mass index (BMI), mode of conception, delivery time, and fetal gender between the two groups of maternal characteristics. There were also no significant differences in the amniotic fluid depth, umbilical artery standard deviation (SD) value, umbilical cord entanglement, placental shape, and twin gender differences between the two groups of neonates. However, the smaller neonates in the DT group had a higher cortisol level in the umbilical cord blood, with a significant difference, while there was no significant difference in cortisol levels in the umbilical cord blood of the CT group of twin fetuses.
Conclusions: The difference in cortisol levels in the umbilical cord blood of twin fetuses may be related to the occurrence of inconsistent growth of dichorionic twins.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12145084 | PMC |
http://dx.doi.org/10.7717/peerj.19479 | DOI Listing |
Br J Haematol
September 2025
Department of Hematology, The First Affiliated Hospital of University of Science and Technology of China, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.
Refractory cytomegalovirus (CMV) infection is a severe complication following umbilical cord blood transplantation (UCBT). Antiviral agents, the standard first-line therapy, are limited by toxicity and resistance without robust T-cell immunity. We evaluated third-party donor (TPD)-derived CMV-specific T cells (CMVSTs) as a treatment option.
View Article and Find Full Text PDFAnn Lab Med
September 2025
Department of Laboratory Medicine, CHA Bundang Medical Center, CHA University, Seongnam, Korea.
Cryopreserved umbilical cord blood (CB) for transplantation is occasionally exposed to room temperature during storage in cord blood banks. We evaluated the effect of room temperature exposure on the quality of cryopreserved CB. Forty frozen CB units stored in liquid nitrogen tanks were exposed to room temperature until they reached a target temperature of -130°C (group I), -60°C (group II), -40°C (group III), or -25°C (group IV) (N=10 in each group) and then re-stored.
View Article and Find Full Text PDFTransplant Cell Ther
September 2025
Department of Hematology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China; Zhejiang Provincial Clinical Research Center for Hematological disorders, Hangzhou, China; Zhejiang Key Laboratory for Precision Diagnosis and Treatment of Hematological Maligancies, Han
Background: Haploidentical hematopoietic stem cell transplantation (haplo-HSCT) offers curative potential for hematologic malignancies but is often limited by high incidences of graft-versus-host disease (GVHD), delayed engraftment, and transplant-related mortality-especially when donors are aged ≥40 years. Umbilical cord blood (UCB) infusion may mitigate these risks by promoting immune tolerance and hematopoietic recovery. However, the efficacy of this strategy in the context of older donors remains insufficiently studied.
View Article and Find Full Text PDFTransplant Cell Ther
September 2025
Department of Hematology, Toranomon Hospital, Tokyo, Japan; Okinaka Memorial Institute for Medical Research, Tokyo, Japan.
Background: Umbilical cord blood transplantation (UCBT) is a valuable treatment option with the potential for curative outcomes in patients with myeloid malignancies in non-remission status, but relapse and early non-relapse mortality (NRM) remain significant barriers. Tacrolimus and mycophenolate mofetil (MMF) are widely used as graft-versus-host disease (GVHD) prophylaxis in UCBT, but there is no consensus on the appropriate MMF dose for GVHD prophylaxis.
Objectives: We conducted a retrospective analysis to investigate the impact of MMF dose on outcomes in patients undergoing UCBT at our institution.
Inflamm Res
September 2025
Department of General Surgery, Beijing Anzhen Hospital, Capital Medical University, No.2 Anzhen Road, Chaoyang District, Beijing, 100029, China.
Background: The roles of long non-coding RNAs (lncRNAs) in the progression of various human tumors have been extensively studied. However, their specific mechanisms and therapeutic potential in Triple-Negative Breast Cancer (TNBC) remain to be fully elucidated.
Materials And Methods: The qRT-PCR assay was utilized to assess the relative mRNA levels of TFAP2A-AS1, PHGDH, and miR-6892.